Looming expiry of tax incentives, rising raw material costs and a fluctuating rupee add to pharma contract manufacturers' woes.
The market size of the segment is expected to be about $7.3 billion (Rs 45,300 crore) for 2013, according to Revati Kasture.
In May, govt had reduced subsidy by 15% for the phosphatic fertilizers in view of fallen global prices and ordered producers to pass on the benefit to farmers.
Andhra Pradesh received the approval from the director general of foreign trade (DGFT) to sell over 8,000 tonne of red sanders.
The bank proposes to raise Rs 200 crore of funds from the govt via preferential allotment route at an offer price to be determined under SEBI norms.
WestBridge Ventures, which currently holds 4.32% stake in India’s only listed micro lender SKS Microfinance, has agreed to buy another 1.74% stake in the micro lender.
Many small & medium drugmakers are under pressure from buyers in foreign markets to cut prices, in line with govt-mandated price cuts in India.
With Seemandhra agitators threatening to target big-budget movies, film-makers take the path of frugal innovation and in Tamil Nadu.
Mid-sized pharmaceutical company Granules India is eying to achieve Rs 1,000 crore of revenue during the current financial year 2013-14.
Big pharmaceutical companies’ profit margins may be under pressure because of a government-induced fall in prices of dozens of medicines, but they could end up with a larger share.
- No blogs yet have been written by the author, we’re sure the author will contribute one soon